Sustained virologic response decreases serum markers of angiogenesis, inflammation, and fibrosis in HIV/HCV-coinfected patients on hepatitis C virus therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS patient care and STDs 2011-03, Vol.25 (3), p.131-133
Hauptverfasser:	García-Álvarez, Mónica, Berenguer, Juan, Micheloud, Dariela, Guzmán-Fulgencio, María, Catalán, Pilar, López, Juan Carlos, Cosín, Jaime, Miralles, Pilar, Carrero-Gras, Ana, Resino, Salvador
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult AIDS/HIV Antiviral Agents - administration & dosage Antiviral Agents - therapeutic use Biomarkers Drug Therapy, Combination Female Hepatitis C - complications Hepatitis C - virology HIV Infections - complications Humans Inflammation - metabolism Interferon-alpha - administration & dosage Interferon-alpha - therapeutic use Liver Cirrhosis - metabolism Male Middle Aged Neovascularization, Pathologic - metabolism Retrospective Studies Ribavirin - administration & dosage Ribavirin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!